UFC Bantamweight Amanda Lemos Notified of Potential Anti-Doping Violation

One-time UFC competitor Amanda Lemos is facing a possible anti-doping violation after failing an out-of-competition drug test.

The Las Vegas-based promotion released a statement on the matter Thursday:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Amanda Lemos of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collected on November 8, 2017.

USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Lemos. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. Additional information will be provided at the appropriate time as the process moves forward.

Lemos made her Octagon debut at UFC Fight Night 113, losing to Leslie Smith via second-round TKO on July 16. The 30-year-old Brazilian posted a 6-0-1 mark on the regional circuit prior to falling to Smith.